New Therapeutic Options in the
Chronic Heart Failure:Optimized Strategies
for Improved Patient Outcomes
A continuing medical education activity sponsored by NAMCP and AAMCN.
This activity is an archive from the
live session at the 2017 Fall Forum. If you participated in
the live session, you are not eligible for continuing education
credits from this archive.
This activity is valid from January 10, 2018 to January 31, 2019
Instructions for CME/CNE: Complete the pre-test, listen to the audio
and view the slides, complete the post test, complete the evaluation
form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your
internet browser without completing the post test, you will have ONE
more opportunity to complete. A score of 70% must be achieved on the
post test to receive continuing education credits. If you do not
pass the post test after two attempts, you will not be eligible to
try again. Once you complete the evaluation form and score 70% or
higher on your post test, you will automatically be given your
To print or save your certificate, you will need to click on the
“download” button and either print or save.
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This presentation is supported by
an educational grant from
Heart failure (HF) is a common condition that affects approximately
5.7 million people in the United States, and the prognosis for
patients with heart failure has traditionally been poor. While
recent efforts have focused on improving the outlook for patients
with chronic heart failure, mortality and morbidity following
admission for acute heart failure remain significant. Fortunately
for patients with chronic HF, new and emerging therapeutic options
have shown the promise for improving outcomes for these patients.
Although multiple therapies have shown to lower mortality in
patients with HF, their applications in clinical practice have been
less than ideal as the 5-year mortality rate and patient
readmissions for HF remain unacceptably high.
Upon Completion of this
activity, participants will be able to:
Summarize the mechanisms of action
and different clinical attributes of new and emerging therapies
for the management of chronic heart failure (HF)
Evaluate methods for individualizing
chronic HF treatment strategies for patients based on specific
patient-related factors to control symptoms, reduce
hospitalizations, and prevent mortality in patients with reduced
Analyze the latest clinical trial
data demonstrating the appropriate use of pharmacologic
interventions in patients with chronic heart failure and reduced
Explore patient management and
communication tools to activate the patient as a key member of
the care team
||R. Scott Wright, MD
Professor of Medicine
serves as a consultant with AstraZeneca,
Boehringer-Ingelheim, The Medicines Company, Regeneron
and Sanofi. He also provides contractual services to the
Mayo Clinic. His presentation has been peer reviewed for any
MD has no real or perceived financial relationships to
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is
accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for
NAMCP designates this enduring material for a maximum of 1 AMA PRA
Category I creditsTM.
The American Association of Managed Care Nurses is accredited as a
provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission
Nurses who complete this activity and achieve a passing score will
receive 1 hour in continuing
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
supported by an educational grant from
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue